Pharmaceutical Executive-12-01-2004
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
2
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
3
CSL Names Deborah Waterhouse as CEO and Manager Director
4
Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds
5